Active, not recruitingNCT00637689
Improving Outcomes Assessment in Chronic GVHD
Studying Chronic graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fred Hutchinson Cancer Center
- Principal Investigator
- Stephanie J Lee, MD MPHFred Hutchinson Cancer Center
- Enrollment
- 601 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2007 – 2027
Study locations (9)
- Stanford University, Stanford, California, United States
- H. Lee Moffitt Cancer Center, Tampa, Florida, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Memorial Sloan Kettering, New York, New York, United States
- Vanderbilt University, Nashville, Tennessee, United States
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
- Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Collaborators
University of Minnesota · Stanford University · Dana-Farber Cancer Institute · Vanderbilt University · Medical College of Wisconsin · Washington University School of Medicine · H. Lee Moffitt Cancer Center and Research Institute · Memorial Sloan Kettering Cancer Center · National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00637689 on ClinicalTrials.govOther trials for Chronic graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07394608Paired Non-invasive VNS in Adolescent Cerebral Palsy RehabilitationIcahn School of Medicine at Mount Sinai
- RECRUITINGPHASE2NCT07124078A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)Incyte Corporation
- RECRUITINGEARLY PHASE1NCT07355868Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell TherapyRegend Therapeutics
- RECRUITINGNANCT06857929"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition"IMDEA Food
- RECRUITINGPHASE1NCT07389044A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis BIntegerBio
- RECRUITINGNCT07127926Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients Suffering From Chronic GvHDM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT07138196A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host DiseaseQurient Co., Ltd.
- ACTIVE NOT RECRUITINGNCT07321080Central Sensitisation in Nociceptive and Neuropathic PainIRCCS Centro Neurolesi Bonino Pulejo